NicOx.... in attesa di.....

[viralic]

DA COME DICONO SU BOURSORAMA orbimed E' SCESA SOTTO LA QUOTA DEL 5% E NON E' CERTO UN BEL SEGNALE.
ORA POSSONO VENDERE SENZA PIU' SEGNALARE NULLA.
NON SO SE CI SONO SOGLIE DEL 2% MA NON MI SEMBRA.

SI....C'è ANCHe quella del 2%

 

[elfrancese]

 

[elfrancese]

qu'en penses tu viralic ?
je dirais que c'est le risque quand tu consens à des Ak réservés aussi basses...
meme si ca ne représente que 15% de leur positions... c'est pas un bon signal...

 

[elfrancese]

espérons que les fidèles des fidèles hbm ne nous fassent le meme tour...

 

[elfrancese]

nous sommes à 4,69 , si on applique une ristourne de 15%, nous arrivons à 4 euro ...

ca serait encore une déception... 1 an de plus, un nCX470 qui progresse et ak consenti 20 centimes plus cher...

 

[viralic]

DA COME DICONO SU BOURSORAMA orbimed E' SCESA SOTTO LA QUOTA DEL 5% E NON E' CERTO UN BEL SEGNALE.
ORA POSSONO VENDERE SENZA PIU' SEGNALARE NULLA.
NON SO SE CI SONO SOGLIE DEL 2% MA NON MI SEMBRA.

hanno venduto come hanno fatto tanti retails....una piccolissima parte dei loro titoli. Tieni conto anche che siamo a fine anno e devono far vedere i risultati ai loro clienti.....

 

[viralic]

qu'en penses tu viralic ?
je dirais que c'est le risque quand tu consens à des Ak réservés aussi basses...
meme si ca ne représente que 15% de leur positions... c'est pas un bon signal...

a fine anno i fondi incassano le plusvalenze ottenute.....non hanno venduto molto azioni .

 

[gigifiori]

Press Release

Nicox Raises €15 million in Private Placement

• Strengthens financial position in advance of upcoming key value inflection points
• Two clinical readouts in Q4 2021 – Mont Blanc Phase 3 for NCX 470 and Mississippi Phase 2b for NCX 4251
• Long-term shareholder HBM Healthcare Investments participated in the financing alongside specialist institutional investors in the U.S. and Europe

Come ci si aspettava...


December 4, 2020 – release at 7:30 am CET
Sophia Antipolis, France

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced a financing through a private placement via the issuance of 3,529,565 new ordinary shares with gross proceeds of €15.0 million.

The Company was previously financed to complete both the Mont Blanc Phase 3 trial for NCX 470 and the Mississippi Phase 2b trial for NCX 4251. Proceeds from this financing extend the cash runway well beyond these key inflection points. Nicox’s principal shareholder HBM Healthcare Investments (SIX:HBMN), a leading, publicly listed healthcare investment fund was joined by new U.S. and European institutional investors in this financing.

 

[PIZZODIGINO]

Dunque 4,25 € è il prezzo; vediamo oggi come va il corso del titolo.

 

[viralic]

Press Release

Nicox Raises €15 million in Private Placement

• Strengthens financial position in advance of upcoming key value inflection points
• Two clinical readouts in Q4 2021 – Mont Blanc Phase 3 for NCX 470 and Mississippi Phase 2b for NCX 4251
• Long-term shareholder HBM Healthcare Investments participated in the financing alongside specialist institutional investors in the U.S. and Europe

Come ci si aspettava...


December 4, 2020 – release at 7:30 am CET
Sophia Antipolis, France

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced a financing through a private placement via the issuance of 3,529,565 new ordinary shares with gross proceeds of €15.0 million.

The Company was previously financed to complete both the Mont Blanc Phase 3 trial for NCX 470 and the Mississippi Phase 2b trial for NCX 4251. Proceeds from this financing extend the cash runway well beyond these key inflection points. Nicox’s principal shareholder HBM Healthcare Investments (SIX:HBMN), a leading, publicly listed healthcare investment fund was joined by new U.S. and European institutional investors in this financing.

E finalmente sto ak è stato fatto.....e ora speriamo solo nelle buone notizie....sino almeno a metà 2022 con il cash siamo a posto.